Controlled "off-on" fluorescent probe for the specific detection of hyperhomocysteinemia

Jinrong Zheng1, Jianlong Li2, Hongli Luo3

  • 1Xiamen Cardiovascular Hospital, Xiamen University Xiamen 361006 China.

RSC Advances
|April 15, 2022
PubMed

Insights

A new fluorescent probe specifically detects homocysteine (Hcy), a risk factor for cardiovascular disease. This tool offers efficient in vivo and in vitro detection of hyperhomocysteinemia for early disease warning.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Cardiovascular Research

Background:

  • Hyperhomocysteinemia is a significant risk factor for atherosclerosis and vascular diseases.
  • Early detection of hyperhomocysteinemia is crucial for preventing cardiovascular diseases.
  • Developing specific probes for homocysteine (Hcy) presents a considerable challenge.

Purpose of the Study:

  • To design and develop a highly selective and sensitive fluorescent probe for homocysteine.
  • To evaluate the probe's anti-interference capabilities against other biological molecules.
  • To assess the probe's efficacy in detecting hyperhomocysteinemia in vitro and in vivo.

Main Methods:

  • Design and synthesis of a novel homocysteine-specific fluorescent probe (HSFP).
  • Spectroscopic analysis to determine probe selectivity and sensitivity towards Hcy.
  • Testing the probe's performance in aqueous solutions with potential interfering substances.
  • Evaluation of HSFP's ability to detect Hcy changes within cells.
  • Application of HSFP for in vivo detection of hyperhomocysteinemia.

Main Results:

  • The developed HSFP exhibits excellent selectivity and anti-interference capabilities.
  • HSFP shows a significant fluorescence attenuation (13.8-fold) in the presence of Hcy in aqueous solutions.
  • The probe effectively detects changes in Hcy content within cells.
  • HSFP demonstrates high efficiency in detecting hyperhomocysteinemia in vivo.

Conclusions:

  • A novel Hcy-specific fluorescent probe (HSFP) has been successfully developed.
  • HSFP offers efficient and selective detection of Hcy in vitro and in vivo.
  • This probe holds potential for early warning and research in cardiovascular diseases related to hyperhomocysteinemia.